These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3594870)

  • 61. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism.
    Schwille PO; Scholz D; Paulus M; Engelhardt W; Sigel A
    Invest Urol; 1979 May; 16(6):457-62. PubMed ID: 447479
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduction of the urinary risk factors of urolithiasis with magnesium and tartrate mixture: a new treatment.
    Hallson PC; Rose GA
    Br J Urol; 1988 May; 61(5):382-4. PubMed ID: 3395794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative study of the effects of pyruvate and CG-120 in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y; Yamaguchi K; Tanaka T; Morozumi M
    Hinyokika Kiyo; 1986 Sep; 32(9):1341-7. PubMed ID: 3812152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of citrate complexes in preventing urolithiasis.
    Ashby RA; Sleet RJ
    Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The in vitro effects of Salmonella enteriditis on urinary stone formation.
    Sarmina I; Resnick MI
    J Urol; 1986 Nov; 136(5):1113-6. PubMed ID: 3534306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance.
    Holmes RP
    Clin Chem; 1995 Sep; 41(9):1297-301. PubMed ID: 7656440
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The value of standard diet in urolithiasis.
    Bastian HP; Vahlensieck W
    Eur Urol; 1975; 1(5):235-7. PubMed ID: 1233189
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Excretion of calcium and citric acid in patients with small bowel disease.
    Elliot JS; Soles WP
    J Urol; 1974 Jun; 111(6):810-2. PubMed ID: 4830886
    [No Abstract]   [Full Text] [Related]  

  • 78. CITRATE INHIBITION OF ALKALINE PHOSPHATASE.
    EVERED DF; STEENSON TI
    Nature; 1964 May; 202():491-2. PubMed ID: 14167833
    [No Abstract]   [Full Text] [Related]  

  • 79. Urinary citrate excretion in patients with renal calculi.
    Menon M; Mahle CJ
    J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of L-cysteine on some urinary risk factors in experimental hyperoxaluric rats.
    Saravanan N; Senthil D; Varalakshmi P
    Br J Urol; 1996 Jul; 78(1):22-4. PubMed ID: 8795394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.